CIBC Private Wealth Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $118M | Sell |
336,736
-46,564
| -12% | -$15.7M | 0.2% | 115 |
|
|
2025
Q3 | $124M | Sell |
383,300
-624,539
| -62% | -$194M | 0.21% | 119 |
|
|
2025
Q2 | $392M | Sell |
1,007,839
-128,202
| -11% | -$51.6M | 0.7% | 33 |
|
|
2025
Q1 | $490M | Buy |
1,136,041
+415,674
| +58% | +$167M | 1.03% | 16 |
|
|
2024
Q4 | $276M | Buy |
720,367
+326,543
| +83% | +$137M | 0.5% | 53 |
|
|
2024
Q3 | $205M | Sell |
393,824
-12,382
| -3% | -$6.61M | 0.37% | 77 |
|
|
2024
Q2 | $214M | Sell |
406,206
-7,063
| -2% | -$3.73M | 0.4% | 68 |
|
|
2024
Q1 | $213M | Sell |
413,269
-8,630
| -2% | -$4.29M | 0.42% | 69 |
|
|
2023
Q4 | $199M | Sell |
421,899
-9,042
| -2% | -$4.18M | 0.42% | 70 |
|
|
2023
Q3 | $188M | Sell |
430,941
-51,451
| -11% | -$23.3M | 0.44% | 62 |
|
|
2023
Q2 | $214M | Sell |
482,392
-80,587
| -14% | -$37.2M | 0.47% | 61 |
|
|
2023
Q1 | $228M | Sell |
562,979
-165,182
| -23% | -$78.6M | 0.51% | 53 |
|
|
2022
Q4 | $45.4M | Buy |
728,161
+17,934
| +3% | +$9.11M | 0.15% | 102 |
|
|
2022
Q3 | $323M | Buy |
710,227
+12,737
| +2% | +$6.09M | 0.87% | 32 |
|
|
2022
Q2 | $337M | Buy |
697,490
+101,279
| +17% | +$50.1M | 0.87% | 30 |
|
|
2022
Q1 | $293M | Buy |
596,211
+168,776
| +39% | +$77.1M | 0.64% | 48 |
|
|
2021
Q4 | $198M | Buy |
427,435
+10,562
| +3% | +$4.44M | 0.41% | 67 |
|
|
2021
Q3 | $155M | Sell |
416,873
-126,109
| -23% | -$47.9M | 0.36% | 77 |
|
|
2021
Q2 | $207M | Buy |
542,982
+234,510
| +76% | +$89.6M | 0.48% | 62 |
|
|
2021
Q1 | $111M | Buy |
308,472
+4,380
| +1% | +$1.41M | 0.28% | 97 |
|
|
2020
Q4 | $97.6M | Buy |
304,092
+7,410
| +2% | +$2.27M | 0.26% | 95 |
|
|
2020
Q3 | $79.7M | Buy |
296,682
+283,961
| +2,232% | +$76.4M | 0.24% | 96 |
|
|
2020
Q2 | $3.35M | Sell |
12,721
-335,572
| -96% | -$89.5M | 0.02% | 329 |
|
|
2020
Q1 | $79.1M | Buy |
348,293
+40,968
| +13% | +$11.2M | 0.34% | 79 |
|
|
2019
Q4 | $92.8M | Buy |
307,325
+400
| +0.1% | +$110K | 0.3% | 97 |
|
|
2019
Q3 | $73.7M | Sell |
306,925
-6,677
| -2% | -$1.83M | 0.26% | 104 |
|
|
2019
Q2 | $88.5M | Sell |
313,602
-234,438
| -43% | -$64M | 0.31% | 91 |
|
|
2019
Q1 | $157M | Sell |
548,040
-198,622
| -27% | -$57.4M | 0.61% | 48 |
|
|
2018
Q4 | $196M | Sell |
746,662
-6
| -0% | -$1.65K | 0.87% | 26 |
|
|
2018
Q3 | $205M | Buy |
746,668
+3,466
| +0.5% | +$900K | 0.78% | 26 |
|
|
2018
Q2 | $177M | Buy |
743,202
+89,501
| +14% | +$20.7M | 0.72% | 33 |
|
|
2018
Q1 | $144M | Sell |
653,701
-11,887
| -2% | -$2.79M | 0.62% | 41 |
|
|
2017
Q4 | $150M | Buy |
665,588
+197,928
| +42% | +$42.2M | 0.64% | 39 |
|
|
2017
Q3 | $88.8M | Buy |
+467,660
| New | +$89M | 0.4% | 75 |
|
Other funds holding ELV
CIBC Private Wealth Group's ELV Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its Elevance Health (ELV) stake by 12% in Q4 2025, selling an estimated $15.7M and leaving 336,736 shares worth $118M. The position accounts for 0.2% of the portfolio, ranked #115.
CIBC Private Wealth Group first reported a position in ELV in Q3 2017 and has held it in 34 quarters since. The position peaked at $490M in Q1 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.
- CIBC Private Wealth Group held 336,736 shares of Elevance Health worth $118M as of Q4 2025.
- CIBC Private Wealth Group sold 46,564 Elevance Health shares in Q4 2025, an estimated $15.7M.
- Elevance Health made up 0.2% of CIBC Private Wealth Group's portfolio in Q4 2025, its #115 holding.
- CIBC Private Wealth Group first reported a position in Elevance Health in Q3 2017 and has held it in 34 quarters since.
- CIBC Private Wealth Group's Elevance Health position peaked at $490M in Q1 2025.
- 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.